The Metal segment, representing approximately 13.6% of market share in 2025, encompasses aluminum foil and tin-plate inner frames primarily used in the luxury and ultra-premium cigarette segments
population reported smoking cigars within the last 30 days in 2018
Accessed October 21, 2022
Time of Day Not applicable Food Not applicable Cigarettes Smoking has no effect on aripiprazole LAI metabolism Pharmacokinetics Volume of distribution 4.9 L/Kg Protein Binding Greater than 99% (primarily to albumin) Elimination half-life After multiple dose administration of 300 mg or 400 mg, the main aripiprazole terminal elimination half-life is 29.9 46.5 days Time to peak (Tmax) 5 7 days Metabolism Primarily hepatic (CYP2D6 & CYP3A4) After multiple dose administration, dehydro-aripiprazole, the active metabolite, represents about 29% of aripirazole AUC in plasma Drug-drug Interactions Potential for Other Drugs to Affect Aripiprazole Aripiprazole is not a substrate of CYP1A1, CYP1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C9, CYP2C19, or CYP2E1 enzymes